Director shareholding

July 28, 2014 Group News
blog_img4

Esperite N.V. (Euronext: ESP, `Esperite`, or `the Group`), the leading international stem cell storage company and the largest family stem cell bank in Europe, has been informed that 242,600 ordinary shares of Euro 0.10 (`Ordinary Shares`) have been transfered to Mr Frederic Amar, Chief Executive Officer, on Friday 11 July 2014.

read more

Director shareholding – Block-trades

May 10, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, has been informed that via a block-trade Mr Johan Goossens, Chairman, sold 900,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) to Salveo Holding SA on 7 May 2013 and that at the same day Mr Marc Waeterschoot, co-founder and former Board Member of Cryo-Save, via a block-trade sold 1,460,000 Ordinary Shares to Salveo Holding SA, both at a price of €1.70. Salveo Holding SA has not contacted management of Cryo-Save about its intentions as a major shareholder.

read more

Director shareholding

November 3, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.14 on 1 November 2011.

Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group’s issued share capital.

read more

Director Shareholding

June 30, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 10,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.92 on 29 June 2011.

read more

Director Shareholding

June 24, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 10,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.95 on 23 June 2011.

read more

Director shareholding

May 27, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Arnoud van Tulder, Chief Executive Officer, purchased 2,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €5.03 on 24 May 2011.

read more

Director/PDMR shareholding

January 10, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has been informed that Mr Ronald Lorijn, Non-Executive Director, purchased 7,354 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.99 on 7 January 2011.

Following this purchase, Ronald Lorijn is beneficially interested in 7,354 ordinary shares, representing approximately 0.08% of the Group’s issued share capital.

read more

Director/PDMR shareholding

December 15, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has been informed that Mr Walter van Pottelberge, Non-Executive Director, purchased 5,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.90 on 13 December 2010.

Following this purchase, Walter van Pottelberge is beneficially interested in 31,210 ordinary shares, representing approximately 0.33% of the Group’s issued share capital.

read more

Director/PDRM shareholding

November 23, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has been informed that Mr Marc Waeterschoot, Executive Director, purchased 20,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €5.10 on 18 November 2010. Following this purchase, Marc Waeterschoot is beneficially interested in 1,853,850 ordinary shares, representing approximately 19.84% of the Group’s issued share capital.

read more

EN – Director/PDMR shareholding

August 2, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Marc Waeterschoot, Executive Director, purchased 23,850 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price range between €5.64 and €5.80 between 26 July and 30 July 2010.

Following this purchase, Marc Waeterschoot is beneficially interested in 1,833,850 ordinary shares, representing approximately 19.84% of the Group’s issued share capital.

read more

Page 1 of 512345